Wikidata

(Q27853111)

English

A neoadjuvant, randomized, open-label phase II trial of afatinib versus trastuzumab versus lapatinib in patients with locally advanced HER2-positive breast cancer

scientific article

In more languages
default for all languages
No label defined

No description defined

Statements

title
A neoadjuvant, randomized, open-label phase II trial of afatinib versus trastuzumab versus lapatinib in patients with locally advanced HER2-positive breast cancer (English)
1 reference
stated in
PubMed
PubMed publication ID
25537159
retrieved
13 November 2016
author
Maira Caleffi
series ordinal
5
object named as
Maira Caleffi
0 references
author name string
Mothaffar F Rimawi
series ordinal
1
0 references
Sabina B Aleixo
series ordinal
2
0 references
Ashley Alarcon Rozas
series ordinal
3
0 references
João Nunes de Matos Neto
series ordinal
4
0 references
Alicardo Cesar Figueira
series ordinal
6
0 references
Sulene Cunha Souza
series ordinal
7
0 references
Andre B Reiriz
series ordinal
8
0 references
Carolina Gutierrez
series ordinal
9
0 references
Heloisa Arantes
series ordinal
10
0 references
Martina M Uttenreuther-Fischer
series ordinal
11
0 references
Flavio Solca
series ordinal
12
0 references
C Kent Osborne
series ordinal
13
0 references
publication date
April 2015
0 references
volume
15
0 references
issue
2
0 references
page(s)
101-9
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q27853111&oldid=1787357702"